フォロー
Xiaochuan Yang
Xiaochuan Yang
Cullgen Inc.
確認したメール アドレス: なし
タイトル
引用先
引用先
FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo
T Sato, X Yang, S Knapper, P White, BD Smith, S Galkin, D Small, ...
Blood, The Journal of the American Society of Hematology 117 (12), 3286-3293, 2011
2922011
Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML
A Sexauer, A Perl, X Yang, M Borowitz, C Gocke, T Rajkhowa, C Thiede, ...
Blood, The Journal of the American Society of Hematology 120 (20), 4205-4214, 2012
1872012
Bone marrow stroma‐mediated resistance to FLT 3 inhibitors in FLT 3‐ITD AML is mediated by persistent activation of extracellular regulated kinase
X Yang, A Sexauer, M Levis
British journal of haematology 164 (1), 61-72, 2014
1452014
Synthesis, antimalarial activity and cytotoxic potential of new monocarbonyl analogues of curcumin
S Manohar, SI Khan, SK Kandi, K Raj, G Sun, X Yang, ADC Molina, N Ni, ...
Bioorganic & medicinal chemistry letters 23 (1), 112-116, 2013
782013
Further activation of FLT3 mutants by FLT3 ligand
R Zheng, E Bailey, B Nguyen, X Yang, O Piloto, M Levis, D Small
Oncogene 30 (38), 4004-4014, 2011
602011
Novel rhein analogues as potential anticancer agents
X Yang, G Sun, C Yang, B Wang
ChemMedChem 6 (12), 2294-2301, 2011
532011
Boronic acid-modified DNA that changes fluorescent properties upon carbohydrate binding
X Yang, C Dai, ADC Molina, B Wang
Chemical communications 46 (7), 1073-1075, 2010
532010
Design, Synthesis, and Structure− Activity Relationship, Molecular Modeling, and NMR Studies of a Series of Phenyl Alkyl Ketones as Highly Potent and Selective …
S Zheng, G Kaur, H Wang, M Li, M Macnaughtan, X Yang, S Reid, ...
Journal of medicinal chemistry 51 (24), 7673-7688, 2008
482008
Chemical Validation of Phosphodiesterase C as a Chemotherapeutic Target in Trypanosoma cruzi, the Etiological Agent of Chagas' Disease
S King-Keller, M Li, A Smith, S Zheng, G Kaur, X Yang, B Wang, ...
Antimicrobial agents and chemotherapy 54 (9), 3738-3745, 2010
452010
Pulsed-high-dose dexamethasone as a treatment for pure red cell aplasia following ABO-incompatible allogeneic stem cell transplantation
X Yang, M Levis
Transfusion Medicine 24 (4), 246-248, 2014
122014
Boronic Acid‐Based Receptors and Chemosensors
X Yang, Y Cheng, S Jin, B Wang
Artificial Receptors for Chemical Sensors, 169-189, 2010
52010
Persistent ERK activation in bone marrow blasts may account for the difference in bone marrow versus peripheral blood response to FLT3 inhibition in FLT3/ITD AML
X Yang, A Sexauer, MJ Levis
Blood 118 (21), 736, 2011
42011
Anthraquinone analogs and methods of making and using thereof
B Wang, C Dai, A Draganov, X Yang, G Sun, C Yang, W Chen, N Ni, ...
US Patent 10,544,090, 2020
32020
Curcumin analogs and methods of making and using thereof
DS Rawat, B Wang, N Kumar, S Manohar, X Yang, G Sun, N Ni
US Patent 9,884,825, 2018
32018
SYNTHETIC LECTIN ARTIFICIAL CARBOHYDRATE RECEPTORS
X Yang, Y Cheng, B Wang
Carbohydrate Recognition: Biological Problems, Methods, and Applications 13, 301, 2011
3*2011
Inotuzumab Ozogamicin Is An Effective Salvage Therapy in Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia with High-Risk Molecular Features, Including TP53 Loss
X Yang, AC King, CC Kabel, CJ Forlenza, JH Park, MB Geyer
Blood 134, 3888, 2019
22019
Covalent Interactions in Chemosensor Design
Y Cheng, X Yang, B Wang
Chemosensors: Principles, Strategies, and Applications, 25-40, 2011
12011
Design and Synthesis of Boronic Acid-Modified Nucleotides for Fluorescent Sensing and Cell Imaging
X Yang
Georgia State University, 2009
12009
Inotuzumab ozogamicin as chemotherapy-sparing salvage in a 67-year-old man with primary refractory B-cell acute lymphoblastic leukemia with high-risk genomic features
X Yang, F Sen, MB Geyer
Leukemia Research Reports 12, 100186, 2019
2019
Synthesis, antimalarial activity and cytotoxic potential of new monocarbonyl analogues of curcumin.
SM Sunny Manohar, SI Khan, SK Kandi, KR Kranthi Raj, GJ Sun, ...
2013
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20